How many 8-K filings has Exozymes Inc. filed?

Exozymes Inc. (EXOZ) has 12 8-K (Current Event Report) filings on record, spanning Nov 2024 to May 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Exozymes Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Exozymes Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Exozymes Inc. (EXOZ) — 8-K Filings

All 8-K filings from Exozymes Inc.. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (12)

8-K Filing — May 7, 2026
8-K Filing — Mar 31, 2026
ExoZymes Inc. Files 8-K on December 11 Event — Dec 12, 2025 Risk: medium
ExoZymes Inc. filed an 8-K on December 12, 2025, reporting an event that occurred on December 11, 2025. The filing indicates a change in the company's status or
ExoZymes Inc. Files 8-K — Oct 3, 2025 Risk: low
ExoZymes Inc. filed an 8-K on October 3, 2025, reporting on events as of September 30, 2025. The filing primarily concerns "Other Events" and "Financial Stateme
ExoZymes Inc. Reports on Shareholder Vote Matters — Jul 28, 2025 Risk: low
ExoZymes Inc. filed an 8-K on July 28, 2025, reporting on a matter submitted to a vote of its security holders as of July 25, 2025. The company, formerly Invizy
ExoZymes Inc. Files 8-K on July 7 Events — Jul 8, 2025 Risk: low
ExoZymes Inc. filed an 8-K on July 8, 2025, reporting on events that occurred on July 7, 2025. The filing primarily concerns "Other Events" and "Financial State
ExoZymes Inc. Files 8-K for Material Agreement — Jun 26, 2025 Risk: medium
ExoZymes Inc. filed an 8-K on June 26, 2025, reporting the entry into a material definitive agreement and financial statements. The company, formerly Invizyne T
ExoZymes Inc. Reports Executive and Director Changes — Jun 20, 2025 Risk: medium
ExoZymes Inc. announced on June 17, 2025, changes in its executive team and board of directors. The company also disclosed compensatory arrangements for certain
ExoZymes Inc. Files 8-K — Apr 2, 2025 Risk: low
ExoZymes Inc. filed an 8-K on April 2, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly Invizyne Technologies Inc.
ExoZymes Inc. Relocates Principal Executive Offices — Feb 21, 2025 Risk: low
ExoZymes Inc. announced on February 17, 2025, a change in its principal executive offices to 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016. The company, f
ExoZymes Inc. Amends Corporate Governance Documents — Feb 11, 2025 Risk: low
ExoZymes Inc. filed an 8-K on February 10, 2025, reporting amendments to its Articles of Incorporation or Bylaws. The filing indicates that the company's common
Invizyne Technologies Files 8-K: Material Agreement — Nov 18, 2024 Risk: medium
Invizyne Technologies Inc. entered into a Material Definitive Agreement on November 14, 2024. The company, incorporated in Nevada with its principal executive o

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX